Canada markets closed

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
32.05+0.91 (+2.92%)
At close: 04:00PM EDT
31.32 -0.73 (-2.28%)
After hours: 06:34PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
223,998
186,374
77,062
19,138
0
Cost of Revenue
59,890
47,039
12,374
1,903
0
Gross Profit
164,108
139,335
64,688
17,235
0
Operating Expenses
Research Development
111,283
102,609
106,842
131,428
81,605
Selling General and Administrative
161,299
145,880
89,066
59,220
22,691
Total Operating Expenses
272,582
248,489
195,908
190,648
104,296
Operating Income or Loss
-108,474
-109,154
-131,220
-173,413
-104,296
Interest Expense
14,440
15,105
15,979
17,590
335
Total Other Income/Expenses Net
-49,332
-51,900
1,271
106,686
-192
Income Before Tax
-157,150
-162,424
-142,071
-83,951
-103,264
Income Tax Expense
1,414
991
-6,406
37
6
Income from Continuing Operations
-158,564
-163,415
-135,665
-83,988
-103,270
Net Income
-158,564
-163,415
-135,665
-83,988
-103,270
Net Income available to common shareholders
-158,564
-163,415
-135,665
-83,988
-103,270
Basic EPS
-4.26
-4.00
-4.01
-2.77
-4.09
Diluted EPS
-4.27
-4.00
-4.02
-2.77
-4.09
Basic Average Shares
38,462
40,885
33,839
30,322
25,252
Diluted Average Shares
38,593
40,885
33,982
30,322
25,252